Everolimus pharmacokinetics in fed versus fasting volunteers
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2011
At a glance
- Drugs Everolimus (Primary)
- Indications Astrocytoma; Breast cancer; Coronary artery restenosis; Diffuse large B cell lymphoma; Gastric cancer; Gastrointestinal stromal tumours; Head and neck cancer; Heart transplant rejection; Liver cancer; Liver transplant rejection; Lung transplant rejection; Neuroendocrine tumours; Pancreatic cancer; Renal cancer; Renal cell carcinoma; Renal transplant rejection; Urogenital cancer
- Focus Pharmacokinetics
- Sponsors Novartis Pharma A.G.
- 27 Jun 2011 New trial record
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.